Literature DB >> 29796052

Pseudotumor Cerebri Syndrome with Resolution After Discontinuing High Vitamin A Containing Dietary Supplement: Case Report and Review.

Jason T Chisholm1, Michelle M Abou-Jaoude2, Amy B Hessler1, Padmaja Sudhakar1.   

Abstract

A 24-year-old non-obese, but slightly overweight, female presented with a two-week history of progressive severe headache associated with two days of blurry vision. Clinical exam was significant for bilateral papilledema and an enlarged blind spot on visual field testing. Contrast enhanced MRI head revealed no space occupying lesion. A lumbar puncture revealed an elevated opening pressure of 38 cm H2O with normal cerebrospinal fluid composition leading to a diagnosis of pseudotumor cerebri syndrome (PTCS). The patient lacked the typical risk factors of high body mass index or obvious antecedent medications; however, on subsequent questioning, she was chronically ingesting a high vitamin A containing weight loss dietary supplement (Thrive W® - Table 1), which we believe had caused intracranial hypertension. Discontinuation of the diet pill and treatment with acetazolamide led to marked improvement of her PTCS. This case highlights the fact that non-traditional products or medications with high vitamin A may cause pseudotumor cerebri, which treating physicians should assess for while dealing with non-obese PTCS patients.

Entities:  

Keywords:  Idiopathic intracranial hypertension; pseudotumor cerebri; secondary pseudotumor; vitamin A toxicity; weight loss supplement

Year:  2017        PMID: 29796052      PMCID: PMC5958954          DOI: 10.1080/01658107.2017.1367931

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  33 in total

1.  Vitamin A intoxication as a cause of pseudotumor cerebri.

Authors:  G MORRICE; W H HAVENER; F KAPETANSKY
Journal:  JAMA       Date:  1960-08-20       Impact factor: 56.272

2.  Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

Authors:  Michael Wall; Michael P McDermott; Karl D Kieburtz; James J Corbett; Steven E Feldon; Deborah I Friedman; David M Katz; John L Keltner; Eleanor B Schron; Mark J Kupersmith
Journal:  JAMA       Date:  2014 Apr 23-30       Impact factor: 56.272

3.  Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension.

Authors:  Judith E A Warner; Paul S Bernstein; Alexander Yemelyanov; Stephen C Alder; Steven T Farnsworth; Kathleen B Digre
Journal:  Ann Neurol       Date:  2002-11       Impact factor: 10.422

4.  Benign intracranial hypertension associated with hypervitaminosis A.

Authors:  M H Feldman; N S Schlezinger
Journal:  Arch Neurol       Date:  1970-01

5.  Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension.

Authors:  Abdolreza Tabassi; Amirali Hassanzadeh Salmasi; Mahmoud Jalali
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

Review 6.  Papilledema and idiopathic intracranial hypertension.

Authors:  Deborah I Friedman
Journal:  Continuum (Minneap Minn)       Date:  2014-08

7.  Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study.

Authors:  Alexandra J Sinclair; Michael A Burdon; Peter G Nightingale; Alexandra K Ball; Peter Good; Timothy D Matthews; Andrew Jacks; Mark Lawden; Carl E Clarke; Paul M Stewart; Elizabeth A Walker; Jeremy W Tomlinson; Saaeha Rauz
Journal:  BMJ       Date:  2010-07-07

8.  Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children.

Authors:  Deborah I Friedman; Grant T Liu; Kathleen B Digre
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

Review 9.  Idiopathic intracranial hypertension.

Authors:  B R Wakerley; M H Tan; E Y Ting
Journal:  Cephalalgia       Date:  2014-05-20       Impact factor: 6.292

Review 10.  Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management.

Authors:  Susan P Mollan; Fizzah Ali; Ghaniah Hassan-Smith; Hannah Botfield; Deborah I Friedman; Alexandra J Sinclair
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-02-17       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.